Current status of commercial colloidal preparations for sentinel lymph node detection

Peptide receptor radionuclide therapy in patients with metastatic progressive pheochromocytoma and paraganglioma: long-term toxicity, efficacy and prognostic biomarker data of phase II clinical trials.

ESMO open·2021

Clinical value of negative 68Ga-PSMA PET/CT in the management of biochemical recurrent prostate cancer patients.

European journal of nuclear medicine and molecular imaging·2020

Combination radium-223 therapies in patients with bone metastases from castration-resistant prostate cancer: A review.

Critical reviews in oncology/hematology·2020

Circulating androgen receptor combined with 18F-fluorocholine PET/CT metabolic activity and outcome to androgen receptor signalling-directed therapies in castration-resistant prostate cancer.

Scientific reports·2017

Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors.

European journal of nuclear medicine and molecular imaging·2015

Fluorodeoxyglucose positron emission tomography in pulmonary carcinoid tumors.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2015